Skip to main content
. Author manuscript; available in PMC: 2015 Sep 10.
Published in final edited form as: Dig Dis Sci. 2014 Feb 7;59(4):886–891. doi: 10.1007/s10620-014-3038-1

Fig. 6.

Fig. 6

Transplant/death rate over time for end stage liver disease (ESLD) patients with hepatocellular disease. When looking at group 1—the patients with hepatocellular injury—again there was a higher transplant/death rate at all three time points. The difference in transplant/death rate reached statistical significance by the 6-month time period, and at 1 year there was a 68 % transplant/death rate in the small LV/IBW group compared to a 51 % transplant/death rate in the large LV/IBW group (p = 0.009)